
Audentes Therapeutics
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases..
Market cap
$25.5m
Enterprise value
($52m)
Share price
$1.14 BOLD
Authorizing premium user...
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases..